| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criterion 7. See AWMSG criteria for appraising a medicine for information. |
|
Medicine details |
|
| Medicine name | pridinol (Myopridin®) |
| Formulation | 3 mg tablet |
| Reference number | 4887 |
| Indication | For the treatment of central and peripheral muscle spasms: lumbar pain, torticollis, general muscle pain, in adults |
| Company | mibe Pharma UK |
| BNF chapter | Central nervous system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 19/04/2021 |